Arkema Shares Jump 2.47% Following UBS Target Upgrade
The specialty chemicals company's stock made significant gains this Thursday, March 12, trading at 55.90 euros during the session, marking a 2.47% increase from the previous day's close of 54.55 euros. This rise occurs as the CAC 40 falls by 0.38% during the session to 8,011.60 points, amid a generally cautious European context.
Recent UBS Recommendation Boosts Arkema
The rebound in Arkema's shares follows a recent move by Swiss bank UBS, which issued a buy recommendation on the stock on March 10, raising its price target from 61 to 62 euros. At the current price of 55.90 euros, this target suggests a potential appreciation of about 10.9%. However, the group is still down by -30.13% over the year, although it has recovered 5.08% in the last three months. On the financial calendar, the next key dates are the publication of the first quarter 2026 results, scheduled for May 6, followed by the annual general meeting set for May 21. These events could provide new insights into the operational trajectory of the specialty chemist.
Technical Breakthrough in Today's Session
Technically, today's session marks a crossing of the 50-day moving average (MM50), positioned at 55.61 euros. This move above a closely watched threshold is a notable signal, especially since the price had been below this reference for several sessions. The 200-day moving average, at 56.69 euros, now becomes the next zone to cross to confirm a possible more sustained turnaround. The Relative Strength Index (RSI) stands at 36, still close to the oversold zone (below 30), reflecting the selling pressure accumulated in recent weeks. The most relevant technical support is established at 50.85 euros. The SBF 120, the reference index to which Arkema belongs, meanwhile loses 0.33% in the session, at 6,065.45 points, highlighting the relative outperformance of the stock this Thursday.
